Exact Mass: 511.2287
Exact Mass Matches: 511.2287
Found 500 metabolites which its exact mass value is equals to given mass value 511.2287
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
omega-COOH-LTE4NAc
Cerebrocrast
Bis(2-propoxyethyl) 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylate
Ile His Asn Glu
Gln His Val Glu
Ser Tyr Lys Asp
Ile Asn His Glu
verruculogen
An organic heterohexacyclic compound that is a mycotoxic indole alkaloid isolated from Penicillium and Aspergillus species. CONFIDENCE Penicillium amphipolaria
Ala Cys Arg Tyr
Ala Cys Tyr Arg
Ala Phe Phe Gln
Ala Phe Gln Phe
Ala Lys Met Tyr
Ala Lys Tyr Met
Ala Met Lys Tyr
Ala Met Tyr Lys
Ala Gln Phe Phe
Ala Arg Cys Tyr
Ala Arg Tyr Cys
Ala Tyr Cys Arg
Ala Tyr Lys Met
Ala Tyr Met Lys
Ala Tyr Arg Cys
Cys Ala Arg Tyr
Cys Ala Tyr Arg
Cys Phe Arg Ser
Cys Phe Ser Arg
Cys His Pro Arg
Cys His Arg Pro
Cys Lys Val Tyr
Cys Lys Tyr Val
Cys Pro His Arg
Cys Pro Arg His
Cys Arg Ala Tyr
Cys Arg Phe Ser
Cys Arg His Pro
Cys Arg Pro His
Cys Arg Ser Phe
Cys Arg Tyr Ala
Cys Ser Phe Arg
Cys Ser Arg Phe
Cys Val Lys Tyr
Cys Val Tyr Lys
Cys Tyr Ala Arg
Cys Tyr Lys Val
Cys Tyr Arg Ala
Cys Tyr Val Lys
Asp Cys Lys Phe
Asp Phe Cys Lys
Asp Phe Lys Cys
Asp His Ile Gln
Asp His Leu Gln
Asp His Gln Ile
Asp His Gln Leu
Asp Ile His Gln
Asp Ile Gln His
Asp Lys Cys Phe
Asp Lys Phe Cys
Asp Lys Ser Tyr
Asp Lys Tyr Ser
Asp Leu His Gln
Asp Leu Gln His
Asp Gln His Ile
Asp Gln His Leu
Asp Gln Ile His
Asp Gln Leu His
Asp Ser Lys Tyr
Asp Ser Tyr Lys
Asp Tyr Lys Ser
Asp Tyr Ser Lys
Glu His Ile Asn
Glu His Leu Asn
Glu His Asn Ile
Glu His Asn Leu
Glu His Gln Val
Glu His Val Gln
Glu Ile His Asn
Glu Ile Asn His
Glu Leu His Asn
Glu Leu Asn His
Glu Asn His Ile
Glu Asn His Leu
Glu Asn Ile His
Glu Asn Leu His
Glu Gln His Val
Glu Gln Val His
Glu Val His Gln
Glu Val Gln His
Phe Ala Phe Gln
Phe Ala Gln Phe
Phe Cys Asp Lys
Phe Cys Lys Asp
Phe Cys Arg Ser
Phe Cys Ser Arg
Phe Asp Cys Lys
Phe Asp Lys Cys
Phe Phe Ala Gln
Phe Phe Gln Ala
Phe Lys Cys Asp
Phe Lys Asp Cys
Phe Lys Met Ser
Phe Lys Ser Met
Phe Met Lys Ser
Phe Met Asn Thr
Phe Met Gln Ser
Phe Met Ser Lys
Phe Met Ser Gln
Phe Met Thr Asn
Phe Asn Met Thr
Phe Asn Thr Met
Phe Gln Ala Phe
Phe Gln Phe Ala
Phe Gln Met Ser
Phe Gln Ser Met
Phe Arg Cys Ser
Phe Arg Ser Cys
Phe Ser Cys Arg
Phe Ser Lys Met
Phe Ser Met Lys
Phe Ser Met Gln
Phe Ser Gln Met
Phe Ser Arg Cys
Phe Thr Met Asn
Phe Thr Asn Met
His Cys Pro Arg
His Cys Arg Pro
His Asp Ile Gln
His Asp Leu Gln
His Asp Gln Ile
His Asp Gln Leu
His Glu Ile Asn
His Glu Leu Asn
His Glu Asn Ile
His Glu Asn Leu
His Glu Gln Val
His Glu Val Gln
His Ile Asp Gln
His Ile Glu Asn
His Ile Asn Glu
His Ile Gln Asp
His Leu Asp Gln
His Leu Glu Asn
His Leu Asn Glu
His Leu Gln Asp
His Met Pro Gln
His Met Gln Pro
His Asn Glu Ile
His Asn Glu Leu
His Asn Ile Glu
His Asn Leu Glu
His Asn Asn Gln
His Asn Gln Asn
His Pro Cys Arg
His Pro Met Gln
His Pro Gln Met
His Pro Arg Cys
His Gln Asp Ile
His Gln Asp Leu
His Gln Glu Val
His Gln Ile Asp
His Gln Leu Asp
His Gln Met Pro
His Gln Asn Asn
His Gln Pro Met
His Gln Val Glu
His Arg Cys Pro
His Arg Pro Cys
His Val Glu Gln
His Val Gln Glu
Ile Cys Asn Tyr
Ile Cys Tyr Asn
Ile Asp His Gln
Ile Asp Gln His
Ile Glu His Asn
Ile Glu Asn His
Ile His Asp Gln
Ile His Glu Asn
Ile His Gln Asp
Ile Asn Cys Tyr
Ile Asn Glu His
Ile Asn Tyr Cys
Ile Gln Asp His
Ile Gln His Asp
Ile Tyr Cys Asn
Ile Tyr Asn Cys
Lys Ala Met Tyr
Lys Ala Tyr Met
Lys Cys Asp Phe
Lys Cys Phe Asp
Lys Cys Val Tyr
Lys Cys Tyr Val
Lys Asp Cys Phe
Lys Asp Phe Cys
Lys Asp Ser Tyr
Lys Asp Tyr Ser
Lys Phe Cys Asp
Lys Phe Asp Cys
Lys Phe Met Ser
Lys Phe Ser Met
Lys Met Ala Tyr
Lys Met Phe Ser
Lys Met Ser Phe
Lys Met Tyr Ala
Lys Ser Asp Tyr
Lys Ser Phe Met
Lys Ser Met Phe
Lys Ser Tyr Asp
Lys Val Cys Tyr
Lys Val Tyr Cys
Lys Tyr Ala Met
Lys Tyr Cys Val
Lys Tyr Asp Ser
Lys Tyr Met Ala
Lys Tyr Ser Asp
Lys Tyr Val Cys
Leu Cys Asn Tyr
Leu Cys Tyr Asn
Leu Asp His Gln
Leu Asp Gln His
Leu Glu His Asn
Leu Glu Asn His
Leu His Asp Gln
Leu His Glu Asn
Leu His Asn Glu
Leu His Gln Asp
Leu Asn Cys Tyr
Leu Asn Glu His
Leu Asn His Glu
Leu Asn Tyr Cys
Leu Gln Asp His
Leu Gln His Asp
Leu Tyr Cys Asn
Leu Tyr Asn Cys
Met Ala Lys Tyr
Met Ala Gln Tyr
Met Ala Tyr Lys
Met Ala Tyr Gln
Met Phe Lys Ser
Met Phe Asn Thr
Met Phe Gln Ser
Met Phe Ser Lys
Met Phe Ser Gln
Met Phe Thr Asn
Met His Pro Gln
Met His Gln Pro
Met Lys Ala Tyr
Met Lys Phe Ser
Met Lys Ser Phe
Met Lys Tyr Ala
Met Asn Phe Thr
Met Asn Thr Phe
Met Pro His Gln
Met Pro Gln His
Met Gln Ala Tyr
Met Gln Phe Ser
Met Gln His Pro
Met Gln Pro His
Met Gln Ser Phe
Met Gln Tyr Ala
Met Ser Phe Lys
Met Ser Phe Gln
Met Ser Lys Phe
Met Ser Gln Phe
Met Thr Phe Asn
Met Thr Asn Phe
Met Tyr Ala Lys
Met Tyr Ala Gln
Met Tyr Lys Ala
Met Tyr Gln Ala
Asn Cys Ile Tyr
Asn Cys Leu Tyr
Asn Cys Tyr Ile
Asn Cys Tyr Leu
Asn Glu His Ile
Asn Glu His Leu
Asn Glu Ile His
Asn Glu Leu His
Asn Phe Met Thr
Asn Phe Thr Met
Asn His Glu Ile
Asn His Glu Leu
Asn His Ile Glu
Asn His Leu Glu
Asn His Asn Gln
Asn His Gln Asn
Asn Ile Cys Tyr
Asn Ile Glu His
Asn Ile His Glu
Asn Ile Tyr Cys
Asn Leu Cys Tyr
Asn Leu Glu His
Asn Leu His Glu
Asn Leu Tyr Cys
Asn Met Thr Phe
Asn Asn His Gln
Asn Asn Gln His
Asn Gln His Asn
Asn Gln Asn His
Asn Thr Phe Met
Asn Thr Met Phe
Asn Tyr Cys Ile
Asn Tyr Cys Leu
Asn Tyr Ile Cys
Asn Tyr Leu Cys
Pro Cys His Arg
Pro Cys Arg His
Pro His Cys Arg
Pro His Met Gln
Pro His Gln Met
Pro His Arg Cys
Pro Met His Gln
Pro Met Gln His
Pro Gln His Met
Pro Gln Met His
Pro Arg Cys His
Pro Arg His Cys
Gln Ala Phe Phe
Gln Ala Met Tyr
Gln Ala Tyr Met
Gln Cys Val Tyr
Gln Cys Tyr Val
Gln Asp His Ile
Gln Asp His Leu
Gln Asp Ile His
Gln Asp Leu His
Gln Glu His Val
Gln Glu Val His
Gln Phe Ala Phe
Gln Phe Phe Ala
Gln Phe Met Ser
Gln Phe Ser Met
Gln His Asp Ile
Gln His Asp Leu
Gln His Glu Val
Gln His Ile Asp
Gln His Leu Asp
Gln His Met Pro
Gln His Asn Asn
Gln His Pro Met
Gln Ile Asp His
Gln Ile His Asp
Gln Leu Asp His
Gln Leu His Asp
Gln Met His Pro
Gln Met Pro His
Gln Asn His Asn
Gln Asn Asn His
Gln Pro His Met
Gln Pro Met His
Gln Thr Thr Tyr
Gln Thr Tyr Thr
Gln Val Glu His
Gln Val His Glu
Gln Tyr Thr Thr
Arg Ala Cys Tyr
Arg Ala Tyr Cys
Arg Cys Ala Tyr
Arg Cys Phe Ser
Arg Cys His Pro
Arg Cys Pro His
Arg Cys Ser Phe
Arg Cys Tyr Ala
Arg Phe Cys Ser
Arg Phe Ser Cys
Arg His Cys Pro
Arg His Pro Cys
Arg Pro Cys His
Arg Pro His Cys
Arg Ser Cys Phe
Arg Ser Phe Cys
Arg Ser Ser Tyr
Arg Ser Tyr Ser
Arg Tyr Ala Cys
Arg Tyr Cys Ala
Arg Tyr Ser Ser
Ser Cys Phe Arg
Ser Cys Arg Phe
Ser Asp Lys Tyr
Ser Asp Tyr Lys
Ser Phe Cys Arg
Ser Phe Lys Met
Ser Phe Met Lys
Ser Phe Arg Cys
Ser Lys Asp Tyr
Ser Lys Phe Met
Ser Lys Met Phe
Ser Lys Tyr Asp
Ser Met Phe Lys
Ser Met Lys Phe
Ser Met Gln Phe
Ser Arg Cys Phe
Ser Arg Phe Cys
Ser Arg Ser Tyr
Ser Arg Tyr Ser
Ser Ser Arg Tyr
Ser Ser Tyr Arg
Ser Tyr Asp Lys
Ser Tyr Arg Ser
Ser Tyr Ser Arg
Thr Gln Thr Tyr
Thr Gln Tyr Thr
Thr Thr Gln Tyr
Thr Thr Tyr Gln
Thr Tyr Gln Thr
Thr Tyr Thr Gln
Val Cys Lys Tyr
Val Cys Tyr Lys
Val Glu His Gln
Val Glu Gln His
Val His Glu Gln
Val His Gln Glu
Val Lys Cys Tyr
Val Lys Tyr Cys
Val Gln Glu His
Val Gln His Glu
Val Tyr Cys Lys
Val Tyr Lys Cys
Tyr Ala Cys Arg
Tyr Ala Lys Met
Tyr Ala Met Lys
Tyr Ala Arg Cys
Tyr Cys Ala Arg
Tyr Cys Lys Val
Tyr Cys Arg Ala
Tyr Cys Val Lys
Tyr Asp Lys Ser
Tyr Asp Ser Lys
Tyr Lys Ala Met
Tyr Lys Cys Val
Tyr Lys Asp Ser
Tyr Lys Met Ala
Tyr Lys Ser Asp
Tyr Lys Val Cys
Tyr Met Ala Lys
Tyr Met Lys Ala
Tyr Gln Thr Thr
Tyr Arg Ala Cys
Tyr Arg Cys Ala
Tyr Arg Ser Ser
Tyr Ser Asp Lys
Tyr Ser Lys Asp
Tyr Ser Arg Ser
Tyr Ser Ser Arg
Tyr Thr Gln Thr
Tyr Thr Thr Gln
Tyr Val Cys Lys
Tyr Val Lys Cys
Litronesib
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
(1S)-2-oxobornane-10-sulphonic acid, compound with 7-[2-(diethylamino)ethyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
FMOC-3-CARBOXYMETHYL-1-PHENYL-1,3,8-TRIAZASPIRO[4 5]DECAN-4-ONE
1,3,5-Triazine, 2,4-diphenyl-6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)[1,1-biphenyl]-3-yl]-
6-[(2R,5R)-3-hydroxy-5-[4-[[(2R)-2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoyl]oxy-6-methyloxan-2-yl]oxyheptanoic acid
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(oxane-4-carbonyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
Upidosin
Upidosin (Rec 15/2739) is an α-1 adrenoceptor (α-1 AR) antagonist. Upidosin shows moderate selectivity for the α-1A AR subtype. Upidosin shows uroselectivity in urethra and prostate with a Kb value of 2-3 nM higher than in ear artery and aorta with a Kb value of 20-100 nM. Upidosin inhibits [3H]prazosin binding to cloned human α-1A adrenergic receptor. Upidosin can be used for the research of urethral obstruction[1].